Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 18.08.16 in Vol 5, No 3 (2016): Jul-Sept

This paper is in the following e-collection/theme issue:

Works citing "Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design"

David Peddie, Serena S Small, Katherin Badke, Maeve E Wickham, Chantelle Bailey, Adam Chruscicki, Christine Ackerley, Ellen Balka, Corinne M Hohl

JMIR Res Protoc 2016 (Aug 18); 5(3):e169 

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.5967):

(note that this is only a small subset of citations)

  1. Chruscicki A, Badke K, Peddie D, Small S, Balka E, Hohl CM. Pilot-testing an adverse drug event reporting form prior to its implementation in an electronic health record. SpringerPlus 2016;5(1)
    CrossRef
  2. Peddie D, Small SS, Badke K, Bailey C, Balka E, Hohl CM. Adverse Drug Event Reporting From Clinical Care: Mixed-Methods Analysis for a Minimum Required Dataset. JMIR Medical Informatics 2018;6(2):e10248
    CrossRef
  3. Small S, Peddie D, Ackerley C, Hohl C, Balka E. Patient experiences with informational discontinuity of care: Bridging the gaps. Procedia Computer Science 2017;113:295
    CrossRef
  4. Hohl CM, Small SS, Peddie D, Badke K, Bailey C, Balka E. Why Clinicians Don’t Report Adverse Drug Events: Qualitative Study. JMIR Public Health and Surveillance 2018;4(1):e21
    CrossRef
  5. Lee CY, Chen YP. Machine learning on adverse drug reactions for pharmacovigilance. Drug Discovery Today 2019;24(7):1332
    CrossRef
  6. Small SS, Hohl CM, Balka E. Organizational implications of implementing a new adverse drug event reporting system for care providers and integrating it with provincial health information systems. Healthcare Management Forum 2019;32(4):208
    CrossRef
  7. Tillman EM, Suppes SL, Feldman K, Goldman JL. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record. The Journal of Clinical Pharmacology 2021;61(2):181
    CrossRef
  8. Hau JP, Brasher PMA, Cragg A, Small S, Wickham M, Hohl CM. Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial. Trials 2021;22(1)
    CrossRef
  9. Small SS, Hohl CM, Balka E. Patient Perspectives on Health Data Privacy and Implications for Adverse Drug Event Documentation and Communication: Qualitative Study. Journal of Medical Internet Research 2021;23(1):e21452
    CrossRef
  10. Fossouo Tagne J, Yakob RA, Dang TH, Mcdonald R, Wickramasinghe N. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review. JMIR Public Health and Surveillance 2023;9:e40080
    CrossRef
  11. Fossouo Tagne J, Yakob RA, Mcdonald R, Wickramasinghe N. Linking Activity Theory Within User-Centered Design: Novel Framework to Inform Design and Evaluation of Adverse Drug Reaction Reporting Systems in Pharmacy. JMIR Human Factors 2023;10:e43529
    CrossRef
  12. Fossouo Tagne J, Yakob RA, Mcdonald R, Wickramasinghe N. Barriers and Facilitators Influencing Real-time and Digital-Based Reporting of Adverse Drug Reactions by Community Pharmacists: Qualitative Study Using the Task-Technology Fit Framework. Interactive Journal of Medical Research 2022;11(2):e40597
    CrossRef
  13. Li R, Curtis K, Van C, Tabish Razi Zaidi S, Yeo CY, Arun Kali C, Zaheen M, Therese Moujalli G, Castelino R. Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework. European Journal of Clinical Pharmacology 2022;78(7):1165
    CrossRef
  14. Vacher A, El Mhamdi S, d’Hollander A, Izotte M, Auroy Y, Michel P, Quenon J. Impact of an Original Methodological Tool on the Identification of Corrective and Preventive Actions After Root Cause Analysis of Adverse Events in Health Care Facilities: Results of a Randomized Controlled Trial. Journal of Patient Safety 2021;17(7):483
    CrossRef
  15. Cragg A, Small SS, Lau E, Rowe A, Lau A, Butcher K, Hohl CM. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes. Drug Safety 2023;46(11):1161
    CrossRef
  16. Fossouo Tagne J, Yakob RA, Mcdonald R, Wickramasinghe N. A Web-Based Tool to Report Adverse Drug Reactions by Community Pharmacists in Australia: Usability Testing Study. JMIR Formative Research 2023;7:e48976
    CrossRef
  17. Hutton S, Vance K, Loftus SM, Roth G, Van Male LM. National Development and Implementation of a Democratized Disruptive Behavior Reporting System in Health Care. Journal of Medical Systems 2023;47(1)
    CrossRef
  18. Lau EY, Small SS, Butcher K, Cragg A, Loh GW, Shalansky S, Hohl CM. An external facilitation intervention to increase uptake of an adverse drug event reporting intervention. Frontiers in Health Services 2023;3
    CrossRef
  19. Lau E, Cragg A, Small S, Butcher K, Hohl C. Characterizing and comparing adverse drug events documented in two spontaneous reporting systems in the Lower Mainland of British Columbia, Canada: A retrospective observational study (Preprint). JMIR Human Factors 2023;
    CrossRef
  20. Ali M, Sewunet A, Shumiye M, Hamza A. Patient safety culture and associated factors among health care workers in south Wollo zone public hospitals, north east Ethiopia. Perioperative Care and Operating Room Management 2024;35:100374
    CrossRef